The University of Texas College of Pharmacy welcomes you to the 32nd "VIRTUAL" Psychiatric Pharmacotherapy Update CE activity offers 18 hours of psychiatric focused continuing education.
On Demand Format The Psychiatric Pharmacotherapy Update On Demand program includes 18 one hour video sessions, complete with additional resources, sessions slides, post-tests, and evaluations. See the full agenda here. Registrants can pick and choose content that is most useful for their practice. Register today, and complete the video modules anytime. Content will be available through 2021. But be sure to register soon. Registration for the on demand program will only be available until May 2021.
Already Registered?
If you had previously registered for this program and are looking to return to content, be sure to log in via the tab above. Once logged in, return to this page (look for the links for quick return on the right left side of the home page). Complete any of the sessions through September 2022.
Bookmark this page! This is the same log on site that will be used during the event for viewing presentation slides and access to complete evaluations for CE credit.
Anytime, return to this page, log in, (if it does not return you automatically to this page, just click the "Assess Content" in the banner on the home page). Then scroll down below, and you will see the webinar links and content inside the tabs below.
Fee
$250.00
CE Hours
18.00
CE Units
1.800
Activity Type
Knowledge
Target Audience(s)
Pharmacists
Physicians
Psychiatrists
Psychologists
Physician Assistant
Social Workers
Advance Practice Nurses (CME)
Nurse Practitoners (CME)
Psychopharmacology Myths or Facts
Tawny Smith, Pharm.D., BCPP.
Associate Professor of Psychiatry
The University of Texas at Austin Dell Medical School
See speaker page, bio, disclosure here (opens new tab)
Marisa S. P. Toups, M.D.
Assistant Professor of Psychiatry
The University of Texas at Austin Dell Medical School
See speaker page, bio, disclosure here (opens new tab)
LEARNING OBJECTIVES
Compare the most commonly believed adverse effect myths to the facts from the literature
Summarize the most commonly observed antipsychotic-induced adverse effects and evidence-based management
Explain the components of the metabolic syndrome, which antipsychotics are most commonly implicated, and ways to mitigate its development
This was a LIVE BROADCAST on Oct 15, now produced as an on demand video session.
Clinical Pharmacologist, San Antonio State Hospital, Texas Department of State Health Services
See speaker page, bio, and disclosure here (opens new tab)
LEARNING OBJECTIVES
Describe the pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs recently marketed as well as drugs approaching the market.
Review pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs that have been released in the past five years.
This was a LIVE BROADCAST session on October 15. The On Demand video version of this session is currently in production.
Dietary and Natural Treatments for Mental Health Disorders: Fact vs. Fiction
Marisa S. P. Toups, M.D.
Assistant Professor of Psychiatry
The University of Texas at Austin Dell Medical School
See speaker page, bio, disclosure here (opens new tab)
LEARNING OBJECTIVES
Describe the relationship of diet and nutrition to mental health status
Catalog the use of complementary & alternative medications (CAM) and dietary approaches in the treatment of psychiatric disorders using literature-supported evidence.
Evaluate safety concerns regarding CAM and dietary adverse effects and drug interactions with common natural and herbal remedies used to treat psychiatric disorders.
This was a LIVE BROADCAST session recorded on October 15 and produced for on demand viewing.
Role of Pharmacologic Agents in Personality Disorders
Samantha Vogel, Pharm.D., BCPP.
Clinical Assistant Professor for Pharmacy Practice
The University of Texas at Austin College of Pharmacy
See speaker page, bio, and disclosure here (opens new tab)
LEARNING OBJECTIVES
Describe the pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs recently marketed as well as drugs approaching the market.
Review pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs that have been released in the past five years.
This was a LIVE BROADCAST session recorded in October 15, and produced for On Demand viewing.
The Management of Treatment Resistant Depression: The Art and Science
Charles Nemeroff, M.D., Ph.D.
Chair and Professor
Department of Psychiatry
The University of Texas at Austin Dell School of Medicine
See speaker page, bio, disclosure here (opens new tab)
LEARNING OBJECTIVES
Explain the latest treatment advances and research findings for treatment-resistant depression (TRD)
Describe the emerging strategies in the use of atypical antipsychotics and new agents in the treatment of TRD
Demonstrate the integration of appropriate psychopharmacologic treatments into a comprehensive treatment plan, including cognitive and behavioral psychotherapies
Discuss the evidence for the following agents in the management of TRD: Ketamine, rTMS, ECT, and DBS
This On Demand Video session - look for the video below once logged in.
See speaker page, bio, disclosure here (opens new tab)
LEARNING OBJECTIVES
Distinguish clinical features, diagnosis, and clinical monitoring tools for best-practice treatment of ADHD in child, adolescent, adult, and aged populations
Appraise the current understanding of the efficacy and safety of ADHD treatments, workup, and the impact of comorbid disease states across the age spectrum
Compare the current and near-horizon ADHD treatments (psychotherapy, nutritional, pharmacotherapy, and “video games”) with regard to mechanism of action, duration of activity, adverse effects, and cost
This On Demand Video session - look for the video below once logged in.
Essential Principles and Practices for Evidence-based Pharmacotherapists
Peter S. Jensen, M.D.
Board Chair and Founder
REACH Institute, NY, NY
Adjunct Professor of Psychiatry
University of Arkansas for Medical Sciences
See speaker page, bio, disclosure here (opens new tab)
LEARNING OBJECTIVES
Discuss the key principles in performing evidence-based assessment and diagnosis of children & adolescents with behavioral, emotional, and/or developmental problems
Describe the role of what constitutes "evidence-based prescribing" of psychotropic agents to children & adolescents with psychiatric disorders
Apply evidence-based assessment, diagnosis, treatment planning, and service delivery to specific real-world clinical cases of child/adolescent psychiatric disorders
This On Demand Video session - look for the video below once logged in.
The Psychological Impact of COVID-19 on Healthcare Professionals: Maintaining Ethical Practice
Victoria Latifses, Ph.D.
Director of Psychology, Austin State Hospital
Adjunct Faculty, St. Edward’s University & Walden University
See speaker page, bio, disclosure here (opens new tab)
LEARNING OBJECTIVES
Describe the differences and similarities between compassion fatigue, vicarious trauma, moral distress and burnout in healthcare professionals
Explain 2 ethical practice considerations that are among the most commonly identified stressors for healthcare professionals during the COVID-19 pandemic
Identify 3 stress-relief strategies to alleviate psychological and emotional stress and improve mental well-being
This On Demand Video session - look for the video below once logged in.
Communicating with Patients about the Prescription Monitoring Program
Marc Fleming, PhD, MPH, RPh
Associate Professor and Chair, Department of Pharmacotherapy
University of North Texas System College of Pharmacy
See speaker page, bio, disclosure below
Ashley (Kristin) Garling, Pharm.D.
Clinical Assistant Professor of Pharmacy Practice
The University of Texas at Austin College of Pharmacy
See speaker page, bio, disclosure below
LEARNING OBJECTIVES
Discuss the impact of mandated Prescription Monitoring Program (PMP) use
Debate pain management in the age of PMP and monitoring of morphine milligram equivalents (MMEs)
Discuss using non-stigmatized and inclusive language with patients to address common situations around controlled substances
This On Demand Video session - look for the video below once logged in.
FACULTY
Dr. Fleming is Associate Professor and Department Chair of Pharmacotherapy at the University of North Texas System College of Pharmacy in Fort Worth, Texas. Dr. Fleming was a practicing pharmacist for 15 years before receiving his PhD in Health Outcomes and Pharmacy Practice from The University of Texas at Austin in 2012. Dr. Fleming is currently working with Texas Health and Human Services Commission on two SAMHSA funded grants concerning prescription drug misuse and addressing the opioid crisis. He has also conducted studies assessing the utilization of the Texas prescription drug monitoring program (PDMP) among pharmacists and emergency physicians. Prior research studies include examining the impact of hydrocodone rescheduling on physician prescribing, as well as analyzing data from the Texas PDMP to identify multiple provider episodes. Dr. Fleming has presented on pharmaceutical drugs of misuse and PDMPs to numerous state and national audiences.
DISCLOSURE: Dr. Fleming has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
Dr. Ashley Garling is currently a Clinical Assistant Professor in the Pharmacy Practice Division of the University of Texas at Austin. Dr. Garling has dedicated her career to pharmacy promotion, patient engagement, and public education. Dr. Garling is fundamentally interested in the evolution of pharmacy utilizing communication and technology.
DISCLOSURE: Dr. Garling has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
This project is funded by Texas Health & Human Services Texas Targeted Opioid Response.
The Texas Targeted Opioid Response offers additional Conditioning education programs in partnership with the UT Austin College of Pharmacy - Pharmacy Addictions Research & Medicine program. These FREE CE sessions provide healthcare professionals a comprehensive review of treatment and prevention approaches for opioid use disorder and opioid overdose. See the free courses below:
Lucas Hill, Pharm.D., BCPS, BCACP
Clinical Assistant Professor
The University of Texas at Austin College of Pharmacy
See speaker page, bio, disclosure here (opens new tab)
LEARNING OBJECTIVES
Describe best practices for opioid overdose prevention
Compare FDA-approved medications for opioid use disorder
Discuss current controversies and ethical issues in opioid use disorder treatment in the COVID 19 era
This On Demand Video session - look for the video below once logged in.
This project is funded by Texas Health & Human Services Texas Targeted Opioid Response.
The Texas Targeted Opioid Response offers additional Conditioning education programs in partnership with the UT Austin College of Pharmacy - Pharmacy Addictions Research & Medicine program. These FREE CE sessions provide healthcare professionals a comprehensive review of treatment and prevention approaches for opioid use disorder and opioid overdose. See the free courses below:
The University of Texas at Austin College of Pharmacy is including this special bonus session for Texas licensed Pharmacists. This session meets the Texas State Board of Pharmacy CPE requirement for law credit.
Please NOTE: This session does not carry CME, APA, or CEU's for other professions.
Texas Pharmacy Law Update
Allison Vordenbaumen Benz, RPh, MS
Executive Director / Secretary
Texas State Board of Pharmacy
FACULTY
Allison Vordenbaumen Benz graduated from the University of Texas, College of Pharmacy in August 1988 and completed a Master’s of Science degree in Pharmacy Administration through the Option II program at the University of Texas at Austin in December 1994. Following graduation, she worked as a community pharmacist in California and Texas.
Allison has been an employee of the Texas State Board of Pharmacy since August 1994 and has served for 6-years as Senior Enforcement Officer, 3-years as Assistant Director of Enforcement, and 14-years as Director of Professional Services before being appointed to her present position on December 1, 2017. In her position as Executive Director, Allison serves as the chief executive officer of the agency and an ex-officio member and secretary of the Board.
Allison is a member of the Capital Area Pharmacy Association; the National Association of State Controlled Substances Authorities; the National Alliance for Model State Drug Laws, Prescription Monitoring Program Resource Group; and the National Charity League, Inc., Capital of Texas Chapter. Her awards include the Texas Pharmacy Association, “Forty Under 40” Award in July 2006.
DISCLOSURE
Allison Benz has no relevant financial relationship(s) with commercial interests or conflicts of interest to disclose.
LEARNING OBJECTIVES
Cite recent changes in pharmacy laws and rules and their impact on daily practice.
Discuss applicability of Texas Pharmacy Laws to preceptor development.
Critically discuss practice scenarios/questions regarding Texas pharmacy laws and rules
FORMAT
This course consists of an MP4 video and downloadable resources in PDF format. The video can be found by clicking on the tab below. After viewing the content, complete the online post-test and evaluation.
CONTINUING EDUCATION CREDIT
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This online activity is approved for 0.15 CEUs (1.50 contact hours) of continuing education credit. In order to receive 1.50 contact hours of CE credit, the participant must watch the video in its entirety, complete the online post-test, and complete the online evaluation. Please make sure NABP profile and date of birth (month/year) are correct under learner's profile in this system.
This program meets the 1 hour Texas Law CPE requirement for Texas relicensure.
Pharmacy Practice Seminar • PPS
This program was recorded at the 68th Pharmacy Practice Seminar (PPS) annual conference that was held on September 26 & 27, 2020 (virtual seminar due to COVID-19). The seminar offers 15+ hours of CPE content. Please visit the PPS website here for more information about the event.
Loading, please wait...
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This online activity is approved for 0.15 CEUs (1.50 contact hours) of continuing education credit. In order to receive 1.50 contact hours of CE credit, the participant must watch the video in its entirety, complete the online post-test, and complete the online evaluation. Please make sure NABP profile and date of birth (month/year) are correct under learner's profile in this system.